Holen Sie sich die Stockscreener-App
11.37
0.26%
-0.03
Handel nachbörslich:
11.37
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$11.40
Offen:
$11.35
24-Stunden-Volumen:
4.10M
Relative Volume:
1.15
Marktkapitalisierung:
$2.27B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-5.4928
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
+2.34%
1M Leistung:
+8.08%
6M Leistung:
-28.63%
1J Leistung:
-41.96%
1-Tages-Spanne:
$11.17
$11.42
1-Wochen-Bereich:
$11.06
$11.79
52-Wochen-Spanne:
$9.85
$20.59
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
11.37 | 2.27B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
554.58 | 198.35B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
196.39 | 57.11B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.02 | 38.90B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
247.34 | 36.94B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
266.44 | 19.56B | 2.96B | 487.70M | 344.00M | 6.6758 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
DENTSPLY SIRONA (NASDAQ:XRAY) Receives "Outperform" Rating from Barrington Research - MarketBeat
Dentsply Sirona (XRAY) Maintains Outperform Rating with $14 Pric - GuruFocus
Dentsply Sirona (XRAY): Baird Lowers Price Target to $12.00 | XR - GuruFocus
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Plans $0.16 Quarterly Dividend - MarketBeat
Dentsply Sirona Keeps Quarterly Dividend at $0.16 per Share, Payable Jan. 9 to Holders of Record as of Dec. 26 - marketscreener.com
Dentsply Sirona declares quarterly dividend of $0.16 per share By Investing.com - Investing.com India
Dentsply Sirona declares $0.16 dividend - MSN
Dentsply Sirona Declares Quarterly Cash Dividend - The Manila Times
Glass Ionomer Cement for Dental Market Industry Growth Is Set - openPR.com
Lazard Asset Management LLC Has $160.51 Million Stock Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA Inc. $XRAY Shares Sold by Engine Capital Management LP - MarketBeat
Armistice Capital LLC Sells 2,498,735 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (NASDAQ:XRAY) Director Gregory Lucier Sells 82,200 Shares - MarketBeat
Dentsply Sirona (XRAY): Reassessing Valuation After Michael Pomeroy’s Appointment as Interim CFO - Sahm
Dentsply Sirona Announces Organizational Changes to Simplify Structure, Enhance Profitability, Improve Operational Performance and Drive Growth - ADVFN
RBF Capital LLC Takes $3.18 Million Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (NASDAQ:XRAY) Now Covered by Analysts at Barclays - MarketBeat
Mercury-Free Dental Implants Materials Market Is Booming So - openPR.com
Barclays Initiates Coverage of DENTSPLY SIRONA (XRAY) with Underweight Recommendation - Nasdaq
Dentsply Sirona Extends Lease at Hobbs Brook Real Estate’s Waltham Campus Through 2032 - Boston Real Estate Times
Barclays Initiates Coverage on Dentsply Sirona (XRAY) with Under - GuruFocus
U.S. Dental Prosthetics Market Intelligence Report 2025-2033 Featuring Dentsply Sirona, 3D Systems, Solventum, Ivoclar Vivadent, Institut Straumann and MoreResearchAndMarkets.com - Business Wire
DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock? - MSN
How Investors Are Reacting To DENTSPLY SIRONA (XRAY) Appointing an Interim CFO With Turnaround Expertise - simplywall.st
Norges Bank Purchases New Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Evaluating the Accuracy of Two Intraoral Scanning Systems in Reproducing Implant Positions for Prosthetic Fabrication: A Cross-Sectional Comparative Study - Cureus
Custom Nightguards Initiated in Dentrix Now Available from Henry Schein - Dentistry Today
DENTSPLY SIRONA Inc. $XRAY Shares Sold by Quantbot Technologies LP - MarketBeat
Landmark study underscores efficacy of Reciproc endodontic system - Dental Tribune US
How dovish Fed policy supports DENTSPLY SIRONA Inc. (DY2) stock2025 Volatility Report & Daily Profit Maximizing Tips - Newser
Will DENTSPLY SIRONA Inc. (DY2) stock maintain strong growthMarket Risk Report & Free High Accuracy Swing Entry Alerts - Newser
Why DENTSPLY SIRONA Inc. (DY2) stock is a strong analyst pickMarket Risk Summary & Growth Focused Investment Plans - Newser
Intraoral Scanners Market Is Going to Boom | Align Technology • - openPR.com
South Korea Dental Anesthesia Market Toward USD 80.5 Billion - openPR.com
Evercore ISI Group Maintains DENTSPLY SIRONA (XRAY) In-Line Recommendation - MSN
Can DENTSPLY SIRONA Inc. stock deliver sustainable ROE2025 Momentum Check & Smart Swing Trading Techniques - Newser
DENTSPLY SIRONA Inc. (XRAY) Stock Forecasts - Yahoo Finance
Dentsply Sirona: Advancing Endodontics through Evidence, Quality, and Innovation - marketscreener.com
Why DENTSPLY SIRONA Inc. (DY2) stock could outperform next yearPortfolio Return Report & Long-Term Safe Investment Ideas - Newser
Manufacturer signs lease renewal in Waltham through 2032 - The Business Journals
Brandes Investment Partners LP Has $5.98 Million Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona Q3 2025 Earnings Preview - MSN
Can Dentsply Sirona Stock Recover If Markets Fall? - Trefis
Why DENTSPLY SIRONA Inc. stock remains resilientDollar Strength & Free Real-Time Market Sentiment Alerts - Newser
U.S. Dental Equipment Market Projections 2025-2032: Key - openPR.com
Is DENTSPLY SIRONA Inc. (DY2) stock considered safe haven2025 Breakouts & Breakdowns & Technical Confirmation Alerts - Newser
Dentsply Sirona Renews Full-Building Lease in Waltham - Connect CRE
VP Johnson Surrenders 9,030 Of Dentsply Sirona Inc [XRAY] - TradingView
DENTSPLY SIRONA Named Top Dividend Stock With Insider Buying and 5.64% Yield (XRAY) - Nasdaq
Dental Caries Detectors Market Set for Dynamic Growth with Key Players Dentsply Sirona, KaVo Kerr, 3M Company - EIN News
Rotary Niti Endodontic Files Market Is Booming So Rapidly: Dentsply Sirona • Mani Inc. • Komet Dental • VDW GmbH - openPR.com
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.46%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):